Abstract
Objective
Concurrent chemoradiotherapy (CCRT) is often performed after total pharyngo-laryngo-esophagectomy (TPLE) or total laryngectomy (TL). Hypothyroidism is one of the side-effects of CCRT. The objective of this study was to ascertain the timing of onset and severity of latent hypothyroidism among patients who underwent radiotherapy (RT) or CCRT after TPLE or TL, using thyroid-stimulating hormone (TSH) as a biomarker, and to explore methods of preventing its development.
Methods
Participants comprised 21 patients who underwent these treatments at Tokyo Medical University Hachioji Medical Center between May 2009 and December 2013. TSH, free thyroxine 3, and free thyroxine 4 levels were used as indicators of thyroid function, and thyroid hormone was administered for TSH levels ≥15 µU/mL.
Results
Post-radiotherapeutic TSH levels in 17 of the 21 patients (81%) were not within the reference value, and 10 (48%) required thyroid hormone therapy. Pharmacotherapy was initiated within 1 year in 5 of these 10 patients (50%), and between 1 and 3 years in the remaining 5 patients. No patient who did not undergo thyroidectomy required hormone therapy. Early evaluation of thyroid function appears important when postoperative RT, including CCRT, is performed in combination with TPLE or TL.
Conclusion
Our study suggested that postoperative CCRT or RT after TPLE or TL, especially hemithyroidectomy, carries a high risk for hypothyroidism.
Similar content being viewed by others
References
Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of head and neck cancer. N Engl J Med 350:1945–1952
Garber JR, Cobin RH, Gharib H et al (2012) Clinical practice guidelines for hypothyroidism in adults: co-sponsored by the American association of clinical endocrinologists and the American thyroid association. Endocr Pract 18:988–1028
Pearce SH, Brabant G, Duntas LH et al (2013) 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J 2:215–228
Surks MI, Ortiz E, Daniels GH et al (2004) Subclinical thyroid disease: scientific reviews and guidelines for diagnosis and management. JAMA 291(2):228–238
Motohashi R, Tsukahara K, Sato H et al (2014) Study of salvage neck dissection for cervical lymph node metastasis of hypopharyngeal carcinoma after concurrent chemoradiotherapy 65:457–463
Cannon CR (1994) Hypothyroidism in head and neck cancer patients: experimental and clinical observations. Laryngoscope 104:1–21
Hancock SL, McDougall IR, Constine LS (1995) Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 31:1165–1170
Aich RK, Ranjan DA, Pal S et al (2005) Iatrogenic hypothyroidism: a consequence of external beam radiotherapy to the head & neck malignancies. J Cancer Res Ther 1:142–146
Mercado G, Adelstein DJ, Saxton JP et al (2001) Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer 92:2892–2897
Ozawa H, Saitou H, Mizutari K et al (2007) Hypothyroidism after radiotherapy for patients with head and neck cancer. Am J Otolaryngol 28:46–49
Tell R, Sjödin H, Lundell G et al (1997) Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 39:303–308
Grande C (1992) Hypothyroidism following radiotherapy for head and neck cancer; multivariate analysis. Radiother Oncol 25:31–36
Nishiyama K, Tanaka E, Tarui Y et al (1996) A prospective analysis of subacute thyroid dysfunction after neck radiation. Int J Radiat Oncol Biol Phys 34:439–444
Hall EJ, Cox JD (1994) Physical and biologic basis of radiation therapy. In: Cox JD (ed) Moss radiation oncology rationale, technique, results. Mosby Co, St Louis, pp 1–66
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No author has any conflict of interest.
About this article
Cite this article
Kojima, R., Tsukahara, K., Motohashi, R. et al. Extent of thyroid resection and thyroid function after postoperative radiotherapy following total laryngectomy or total pharyngo-laryngo-esophagectomy. Int J Clin Oncol 22, 438–441 (2017). https://doi.org/10.1007/s10147-016-1082-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-016-1082-x